Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Discover how researchers have overcome a significant chemical hurdle in methylphenidate, potentially paving the way for more effective treatments for cocaine addiction.
Psychiatry September 12th 2023
Northwestern Medicine
Northwestern Medicine’s recent study uncovers a novel interaction between lysosomes and mitochondria, disrupted by mutations in the parkin gene, contributing to Parkinson’s disease. This discovery offers a new therapeutic pathway and emphasizes the significance of organelle communication in neurodegenerative disorders.
Neurology August 22nd 2023
DocWire News
The targeted chemotherapy pill AOH1996, developed by the City of Hope, has shown promising results in preclinical research by targeting PCNA, a protein once thought to be too challenging for targeted therapy. Explore the potential of this novel approach as it advances to phase 1 clinical trials.
Oncology, Medical August 14th 2023
OBR Oncology
Learn about a ground-breaking strategy for treating uncommon brain tumors like papillary craniopharyngiomas (PCPs), where precision medicine and BRAF/MEK inhibitors marked a major improvement in brain cancer treatment by drastically reducing tumor size.
Neurology July 18th 2023
Explore how thought control has been utilized in groundbreaking technology to enable a paralyzed man to walk naturally again, unveiling a new frontier in neuroscience and potentially revolutionizing paralysis treatment.
Neurology July 6th 2023
The New England Journal of Medicine
Discover how a groundbreaking trial using a new CRISPR gene-editing technique has successfully treated a patient with T-cell leukemia, a form of the disease resistant to conventional treatments. Learn how this innovative approach could revolutionize the treatment of various diseases affecting the blood, bone marrow, and immune systems.
Hematology/Oncology June 27th 2023